readthroughSign in
CompanyMDGLNasdaqWest Conshohocken, PA

Madrigal Pharmaceuticals, Inc.

Madrigal Pharmaceuticals develops Rezdiffra (resmetirom), an oral THR-β agonist for metabolic dysfunction-associated steatohepatitis with moderate to advanced fibrosis.

SCHEDULE 13G/ANov 16Latest SEC filing
Nov 3Latest story